Literature DB >> 2172321

Importance of sampling method in DNA analysis of lung cancer.

F A Carey1, D Lamb, C C Bird.   

Abstract

Lung carcinomas are characterised by considerable histological variation within the tumour. The possible effects of this morphological heterogeneity on the estimation of tumour ploidy were investigated. Multiple tissue blocks were systematically taken from 20 lung tumours and analysed by flow cytometry. The routine, archival paraffin wax embedded diagnostic blocks from these cases were also analysed. Nineteen (95%) of the tumours were shown to contain aneuploid stemlines by systematic sampling, but if only one of these systematic tissue blocks had been taken from each case the incidence of DNA aneuploidy could have been as low as 45%. Only 15 (75%) tumours were aneuploid when all the routine archival blocks were analysed, but by specifically selecting tumour areas from the archival material the accuracy of this method was increased to 90%. It is concluded that tumour sampling methods are of primary importance in assessing the DNA content of lung tumours. Routine paraffin wax embedded archival tissue provides a suitable source of material for this purpose, provided that "turnover" selection is carried out.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2172321      PMCID: PMC502831          DOI: 10.1136/jcp.43.10.820

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  9 in total

1.  The percentage of aneuploid cells is significantly correlated with survival in accurately staged patients with stage 1 resected squamous cell lung cancer and long-term follow up.

Authors:  P C van Bodegom; J P Baak; C Stroet-van Galen; N W Schipper; E C Wisse-Brekelmans; R G Vanderschueren; S S Wagenaar
Journal:  Cancer       Date:  1989-01-01       Impact factor: 6.860

2.  Lung cancer heterogeneity: a blinded and randomized study of 100 consecutive cases.

Authors:  V L Roggli; R T Vollmer; S D Greenberg; M H McGavran; H J Spjut; R Yesner
Journal:  Hum Pathol       Date:  1985-06       Impact factor: 3.466

3.  Cellular heterogeneity in lung cancer.

Authors:  M S Dunnill; K C Gatter
Journal:  Histopathology       Date:  1986-05       Impact factor: 5.087

4.  Intratumoral heterogeneity of DNA content in lung cancer.

Authors:  F A Carey; D Lamb; C C Bird
Journal:  Cancer       Date:  1990-05-15       Impact factor: 6.860

5.  Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry.

Authors:  D W Hedley; M L Friedlander; I W Taylor; C A Rugg; E A Musgrove
Journal:  J Histochem Cytochem       Date:  1983-11       Impact factor: 2.479

6.  Prognostic significance of flow cytometry in lung cancer. A 5-year study.

Authors:  D Tirindelli-Danesi; L Teodori; F Mauro; C Modini; C Botti; F Cicconetti; S Stipa
Journal:  Cancer       Date:  1987-08-15       Impact factor: 6.860

7.  Diagnostic and biological implications of flow cytometric DNA content analysis in lung cancer.

Authors:  P A Bunn; D N Carney; A F Gazdar; J Whang-Peng; M J Matthews
Journal:  Cancer Res       Date:  1983-10       Impact factor: 12.701

8.  Ploidy as a prognostic determinant in surgically treated lung cancer.

Authors:  P V Zimmerman; G A Hawson; M H Bint; P G Parsons
Journal:  Lancet       Date:  1987-09-05       Impact factor: 79.321

9.  Immunocytochemical detection of human lung cancer heterogeneity using antibodies to epithelial, neuronal, and neuroendocrine antigens.

Authors:  J L Broers; M K Rot; T Oostendorp; A Huysmans; S S Wagenaar; A J Wiersma-van Tilburg; G P Vooijs; F C Ramaekers
Journal:  Cancer Res       Date:  1987-06-15       Impact factor: 12.701

  9 in total
  3 in total

Review 1.  The study of endocrine tumors by flow and image cytometry.

Authors:  Ingrid Zbieranowski; David Murray
Journal:  Endocr Pathol       Date:  1992-06       Impact factor: 3.943

2.  Predictive and prognostic molecular markers for cancer medicine.

Authors:  Sunali Mehta; Andrew Shelling; Anita Muthukaruppan; Annette Lasham; Cherie Blenkiron; George Laking; Cristin Print
Journal:  Ther Adv Med Oncol       Date:  2010-03       Impact factor: 8.168

3.  Synchronous primary lung cancers: prevalence in surgical material and clinical implications.

Authors:  F A Carey; S C Donnelly; W S Walker; E W Cameron; D Lamb
Journal:  Thorax       Date:  1993-04       Impact factor: 9.139

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.